Insight Blog

Moving On – China FDA – 7 Notices of Personnel Appointments

On March 17, 2016, the CFDA has consecutively issued 7 notices of personnel appointments and dismissals, and the details are as follows:

Appoint Liu Pei as the Director of the Department of Medical Device Supervision with a one-year probationary period.

 

A bit more about Liu Pei, Curriculum vitae:

 

Liu Pei officially served as the Director of the Department of Policies and Regulations of the CFDA in January 2008 after a one-year probationary period; during his time in office, the Department of Policies and Regulations has formulated and revisedan administrative regulation of the State Council- “Regulations on Supervision and Management of Medical Devices”, and passed the “Methods of Medical Device Recall Management” and other departmental rules.

In late 2012, Liu was reappointed as the secretary of the Party Committee of the China Pharmacopoeia Committee (Director-General rank) and the vice Secretary-General of the China Pharmacopoeia Committee;

In late 2013, Liu was reappointed as the Director of the Centre for Complaints and Reports (Director-General rank);

In late 2014, Liu was appointed as the secretary of the Party Committee of the Centre for Administrative Matter Acceptance Services, Complaints and Reports of the CFDA and the Director of the Centre for Administrative Matter Acceptance Services, Complaints and Reports of the CFDA.

In March, 2016, Liu was reappointed as the Director of the Department of Medical Device Supervision.

 

Appoint:

Sun Xianze as the Director of the Information Center (concurrent).

Li Haifeng as the Commissioner of the National Food and Drug Inspection (Leading Post of Director-General rank of Departments) (Working in the Department of Media and Publicity);

Li Qijian as the Commissioner of the National Food and Drug Inspection (Leading Post of Director-General rank of Departments) (Working in the Department of Human Resources);

Liu Fuquan as the Director of the Centre for Acceptance and Reports, and the secretary of the Party Committee Secretary of the Centre for Acceptance and Reports.

Ding Yifang as the Director of the Department of Human Resources, and moving on from the post of the standing vice secretary of the Party Committee of the Institution.

Duan Yongsheng as the standing vice secretary of the Party Committee of the Institution, moving on from the post of the Commissioner of the National Food and Drug Inspection.

Li Bo as the Director-General of the National Institutes for Food and Drug Control;

Yao Xueliang as the vice secretary of the Party Committee of the National Institutes for Food and Drug Control;

Zhang Wei as the secretary of the Party Committee of the China Pharmacopoeia Committee;

Yan Wenjun as the vice secretary of the Party Committee of the Center for Drug Evaluation and the secretary of the Commission for Discipline Inspection of the Center for Drug Evaluation;

Li Jianming as the Deputy Director of the Center for Food and Drug Inspection;

Dong Jiangping as the Deputy Director of the Center for Food and Drug Inspection;

Guo Qingwu as the Deputy Director of the National Committee on the Assessment of the Protected Traditional Chinese Medicinal Products (the Food and Drug Administration Center of the CFDA);

Hou Renping as the Deputy Director of the Center for Drug Evaluation;

Chen Feng and An Fudong as the Deputy Director of the Information Centre;

Luo Jie as the vice secretary of the Party Committee of the Institute of Executive Development and the secretary of the Commission for Discipline Inspection of the Institute of Executive Development;

Wang Aiguo as the deputy secretary general of the Chinese Pharmaceutical Association;

Xue Bin as the Director of the China Centre for Food and Drug International  Exchange (Deputy Director-General rank of Departments).

Cao Guofang as the vice secretary of the Party Committee of the Centre for Medical Device Technical Evaluation and the secretary of the Commission for Discipline Inspection of the Centre for Medical Device Technical Evaluation.

 

A bit more about Cao Guofang, Curriculum vitae:

 

Cao Guofang was appointed as the Deputy Director of the Centre for Medical Device Technical Evaluation of the CFDA (one-year probationary period) in March, 2010.

In late 2014, Cao continued serving as the Deputy Director of the Centre for Medical Device Technical Evaluation;

In March, 2016, Cao was reappointed as the vice secretary of the Party Committee of the Centre for Medical Device Technical Evaluation and the secretary of the Commission for Discipline Inspection of the Centre for Medical Device Technical Evaluation.

Xu Wei was appointed as the Deputy Director of the Centre for Medical Device Technical Evaluation with one-year probationary period.

Xu Wei is also currently serving as the Office Director of the Centre for Medical Device Technical Evaluation. Previously, he has also taken up the post of the Director of the Division of Evaluation.

Deng Gang was appointed as the Deputy Director of the Centre for Medical Device Technical Evaluation with one-year probationary period. Previously, Deng Gang was serving as the Director of the Division of Registration Ⅰof the Department of Medical Device Registration Management.

The Medical Device Classification Technical Committee of the CFDA was founded in late 2015. The first session of the executive committee is formed by 36 committee members including Deng Gang and Xu Wei.

The personnel hereinbefore are dismissed from the original posts and subjected to a one-year probation period.

Remove Guo Wenqi from the post of Director of the Department of Human Resources (concurrent post).

Dismiss Zhang Macao from the post of Director of the 146 Warehouse.

Retire Wei Jianhua from the post of the Inspector of the Department of Medical Device Registration. The retirement formalities will be handled in accordance with the relevant regulations.

 

Summary

The Following 11 persons are subjected to a one-year probationary period: Yan Wenjun, Li Jianming, Dong Jiangping, Guo Qingwu, Xu Wei, Deng Gang, Chen Feng, An Fudong, Luo Jie, Wang Aiguo and Xue Bin. The probationary period for Hou Renping is executed according to the No.11 Document of the CFDA Party Appointments (2015)

The following 9 persons have moved on from their original posts: Yan Wenjun, Dong Jiangping, Guo Qingwu, Hou Renping, Cao Guofang, Deng Gang, An Fudong, Luo Jie and Xue Bin.

 

Share the Post:

Related Posts

Medlab Asia & Asia Health 2024

Medlab Asia & Asia Health 2024 served as a premier international trade exhibition and congress to connect medical laboratories and healthcare industry leaders across Southeast Asia.

Read More